Labiotech.eu

Merck, drug development, lab work, lab worker, scientist

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Biotech firms partner with contract development and manufacturing organizations (CDMOs) to leverage their expertise in process development, optimization, and scale-up. In this article, we share an exclusive sneak-peek into a recent survey, which explores the main reasons why biotech companies collaborate with CDMOs at different stages of drug development. To make a new drug candidate […]

January 26, 2022 - 8 minutesmins - By Sudha Sundaram

Kees Melief Chief Scientific Officer ISA Pharmaceuticals

Expert Advice 24 Jan 2022

Transitioning from Academia to Chief Scientific Officer in the Biotech Industry

Academics with a drive to turn their research into commercial products often end up in the position of Chief Scientific Officer at a biotech company. Kees Melief shares his own personal experience transitioning from academia to industry. After his retirement as an academic researcher at Leiden University, Cornelis ‘Kees’ Melief founded and became the Chief […]

January 24, 2022 - 5 minutesmins - By Victor Kotsev

Gene therapy genenta science genflow biosciences

News and Trends 21 Jan 2022

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science and Genflow Biosciences. The firms aim to shine as biotech stocks elsewhere perform poorly. Until recently, European gene therapy companies were going through a dry spell in terms of launching initial public offerings (IPO). The […]

January 21, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 19 Jan 2022

Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration

With the close of its Series A round at €48M ($54M), the tissue models company Engitix has shifted its business from providing drug discovery services to developing its own treatment pipeline for liver diseases. When Engitix was spun out of University College London in 2016, the startup primarily aimed to provide tissue models to pharmaceutical […]

January 19, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 19 Jan 2022

Glycans Hit the Sweet Spot in Diagnostics

The surface of our cells are covered in sugar molecules called glycans. The field of glycomics leverages their enormous diversity to develop better and more precise diagnostics. More commonly known as sugars or carbohydrates, glycans are involved in a range of crucial biological roles, including maintaining tissue elasticity, tackling pathogens, and modulating the immune system. […]

January 19, 2022 - 5 minutesmins - By Sachin Rawat

ori biotech cell therapy manufacturing cells

News and Trends 18 Jan 2022

Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection. The round was 40% oversubscribed and led by the US investment firm Novalis LifeSciences. The Chinese investor Puhua Capital and Chimera Abu Dhabi joined the existing syndicate, which includes […]

January 18, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 18 Jan 2022

Biomining: Turning Waste into Gold with Microbes

High-value metals make the modern world go round, but the way we extract and dispose of them is far from sustainable. Biomining could be an elegant and lucrative alternative. From the gold and silver in consumer electronics to the rare earth elements needed to power renewable energy technologies, metals underpin the transition to a high-tech, […]

January 18, 2022 - 7 minutesmins - By Farhan Mitha

bioreactor, cell culture expansion, perfusion, biomanufacturing

How to Make Cell Culture Expansion Easy

Cell culture expansion for biotherapeutic development has traditionally involved a series of time-consuming, labor-intensive batch cultures that are susceptible to contamination. Cell culture expansion using a perfusion process promises easy scalability, ensures high productivity gains, and saves time and costs during large-scale biomanufacturing. Cell culture is a crucial tool in the biotech sector. Applications range […]

January 18, 2022 - 7 minutesmins - By Sudha Sundaram

Inside Labiotech 18 Jan 2022

Labiotech.eu Is Being Acquired by Inova

We’ve got some amazing news we’re dying to tell you about, and now we can finally let the cat out of the bag: Inova, the leading biopharma partnering platform has acquired Labiotech! Ever heard of Inova? Inova is a cloud-based solution helping life science companies locate and manage their partnering opportunities more efficiently. The company […]

January 18, 2022 - 2 minutesmins - By Joachim Eeckhout

News and Trends 17 Jan 2022

Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments

The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant Novo Nordisk to search for treatments controlling food intake and other factors contributing to obesity. Under the joint project, EraCal and Novo Nordisk will research targets for obesity treatments by identifying molecules that can control appetite and improve metabolic health. […]

January 17, 2022 - 3 minutesmins - By Dan Samorodnitsky

News and Trends 14 Jan 2022

Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021

Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European firms missed out on the funding growth. Companies around the world developing cell and gene therapies raised €20.1B ($23.1B) over 2021, said the advanced therapy advocacy organization the Alliance for Regenerative Medicine (ARM) in a briefing this week. This bumper […]

January 14, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 13 Jan 2022

Biotech Startup Incubators Prepare to Cash in on Record VC Funding

Venture capital funding broke records in the biotech industry in 2021. Leading startup incubators from across Europe share their plans to make the most of this trend in 2022, with expectations for big returns and expansion in the works. In spite of financial volatility resulting from the Covid-19 pandemic, the year 2021 broke records for […]

January 13, 2022 - 7 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

Transitioning from Academia to Chief Scientific Officer in the Biotech Industry

Two Gene Therapy Players Launch IPOs on Stormy Stock Market

Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration

Glycans Hit the Sweet Spot in Diagnostics

Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture

Biomining: Turning Waste into Gold with Microbes

How to Make Cell Culture Expansion Easy

Labiotech.eu Is Being Acquired by Inova

Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments

Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021

Biotech Startup Incubators Prepare to Cash in on Record VC Funding

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!